Log In
Print
BCIQ
Print
Print this Print this
 

MRX-6, MRX6

  Manage Alerts
Collapse Summary General Information
Company Celsus Therapeutics plc
DescriptionTopical multifunctional anti-inflammatory compound that inhibits phospholipase A2 (PLA2)
Molecular Target Phospholipase A2 (PLA2)
Mechanism of ActionPhospholipase A2 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat allergic contact dermatitis; Treat atopic dermatitis (eczema); Treat mild to moderate atopic dermatitis in pediatric patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today